An updated patent review of Mcl-1 inhibitors (2020-2022)
{{output}}
Introduction: Myeloid leukemia 1 (Mcl-1), an antiapoptotic protein of the Bcl-2 family, is an attractive target for cancer therapy. In recent years, significant progress has been made with regard to Mcl-1 inhibitors, leading to t... ...
